CTLA-4 Blockade Induces CD4⁺ T Cell IFNγ-Driven Microglial Phagocytosis and Anti-Tumor Function in Glioblastoma

Scientists found that treatment with αCTLA-4, but not αPD-1, prolonged survival in a mouse model of mesenchymal-like glioblastoma.